Cayman

STING M284 variant (human, recombinant)

CHF 909.00
In stock
CAY-23594-100100 µgCHF 909.00
 
More Information
Product Details
Synonyms Endoplasmic Reticulum Interferon Stimulator; ERIS; hSTING; MITA; Stimulator of Interferon Genes Protein; TMEM173; Transmembrane Protein 173
Product Type Protein
Properties
Sequence N-terminal His-tagged human recombinant protein expressed in E. coli.
Purity ≥80% (SDS-PAGE)
Formulation 50 mM HEPES, pH 8.0 with 150 mM sodium chloride and 10% glycerol
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Cayman Chemicals.
Shipping and Handling
Shipping DRY ICE
Long Term Storage -80°C
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description
STING M284 variant (human, recombinant) contains amino acids 138-379 of the wild-type variant (R232) with a methionine substituted for arginine at position 284. Stimulator of interferon genes (STING) is a component of the innate immune response that binds to cyclic dinucleotides, which are bacterial second messengers, leading to activation of NF-κB and transcription of immunomodulatory genes, including type I interferon (IFN). The R232 variant of STING is the most common variant in the human population, found at a frequency of 57.9% in the 1000 Genome Project. The SNP variant H232 is found at a 13.7% frequency. The R284M mutation in STING is associated with constitutive activation of downstream signaling. It increases the propensity of STING to dimerize and associate with the kinase TBK1, enhancing the ability of STING to activate IRF3 and NF-κB and induce a type I IFN response. However, the R284M mutation occurs outside of the dimerization region between positions 153-177, so rather than a direct effect on dimerization, it is predicted to promote or inhibit binding of a cellular factor that stabilizes or impairs STING dimerization.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.